- Home
- MNSB vs CVRX Comparison
MNSB vs CVRX Comparison
Compare MNSB & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNSB
- CVRX
- Stock Information
- Founded
- MNSB 2003
- CVRX 2000
- Country
- MNSB United States
- CVRX United States
- Employees
- MNSB N/A
- CVRX N/A
- Industry
- MNSB Major Banks
- CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- MNSB Finance
- CVRX Health Care
- Exchange
- MNSB Nasdaq
- CVRX Nasdaq
- Market Cap
- MNSB 149.7M
- CVRX 174.4M
- IPO Year
- MNSB N/A
- CVRX 2021
- Fundamental
- Price
- MNSB $20.21
- CVRX $7.09
- Analyst Decision
- MNSB
- CVRX Buy
- Analyst Count
- MNSB 0
- CVRX 7
- Target Price
- MNSB N/A
- CVRX $14.50
- AVG Volume (30 Days)
- MNSB 68.8K
- CVRX 178.1K
- Earning Date
- MNSB 07-28-2025
- CVRX 07-28-2025
- Dividend Yield
- MNSB 1.97%
- CVRX N/A
- EPS Growth
- MNSB N/A
- CVRX N/A
- EPS
- MNSB N/A
- CVRX N/A
- Revenue
- MNSB $59,896,000.00
- CVRX $52,870,000.00
- Revenue This Year
- MNSB $17.95
- CVRX $11.53
- Revenue Next Year
- MNSB $2.52
- CVRX $18.61
- P/E Ratio
- MNSB N/A
- CVRX N/A
- Revenue Growth
- MNSB N/A
- CVRX 25.62
- 52 Week Low
- MNSB $15.00
- CVRX $4.30
- 52 Week High
- MNSB $20.88
- CVRX $18.55
- Technical
- Relative Strength Index (RSI)
- MNSB 66.87
- CVRX 61.51
- Support Level
- MNSB $20.08
- CVRX $6.30
- Resistance Level
- MNSB $20.76
- CVRX $7.21
- Average True Range (ATR)
- MNSB 0.39
- CVRX 0.34
- MACD
- MNSB 0.20
- CVRX 0.15
- Stochastic Oscillator
- MNSB 77.80
- CVRX 85.03
About MNSB MainStreet Bancshares Inc.
MainStreet Bancshares Inc is a bank holding company. It is focused on serving the borrowing, cash management and depository needs of small to medium-sized businesses, and professional practices and retail customers. The bank's products and services include business and consumer checking, premium interest-bearing checking, business account analysis, savings, certificates of deposit and other depository services, as well as a broad array of commercial, real estate and consumer loans.
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.